Evidence map›Paper›PMID 35646616›Full record

ArticleAnnals of global health2022

Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis.

Elochukwu Fortune Ezenwankwo, Daniel A Nnate, Catherine Adebukola Oladoyinbo, Hassan Mohammed Dogo, Ademola Amos Idowu, Chimdimma Peace Onyeso, Chidiebere Ndukwe Ogo, Motolani Ogunsanya, Olufikayo Bamidele, Chukwudi A Nnaji

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 5 countries.

Elochukwu Fortune EzenwankwoDivision of Physiological Sciences, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.ORCID 0000-0001-8483-9302
Daniel A NnateDepartment of Nursing and Community Health, School of Health and Life Sciences, Glasgow Caledonian University, UK.ORCID 0000-0002-8432-9377
Catherine Adebukola OladoyinboAfrican Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.
Hassan Mohammed DogoAfrican Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.
Ademola Amos IdowuAfrican Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.
Chimdimma Peace OnyesoMilitary Hospital, GRA, Port Harcourt, Rivers State, Nigeria.
Chidiebere Ndukwe OgoDepartment of Surgery, Federal Medical Centre Abeokuta, NG.
Motolani OgunsanyaCollege of Pharmacy, University of Oklahoma Health Sciences Center, 1110 N. Stonewall Ave, Oklahoma City, US.ORCID 0000-0002-4005-0446
Olufikayo BamideleInstitute for Clinical and Applied Health Research, Hull York Medical School, R341, University of Hull, UK.ORCID 0000-0003-2235-9463
Chukwudi A NnajiCancer Research Initiative, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.ORCID 0000-0002-4132-1922
Federal University of Agriculture · NGEkiti State University · NGGlasgow Caledonian University · GBSouth African Medical Research Council · ZAUniversity of Cape Town · ZAUniversity of Hull · GBUniversity of Oklahoma Health Sciences Center · USUniversity of Port Harcourt Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two years after SARS-CoV-2 (COVID-19) was declared a global public health emergency, the restoration, at least, to the pre-pandemic level of early diagnostic services for prostate cancer has remained enormously challenging for many health systems, worldwide. This is particularly true of West Africa as the region grapples also with the broader impacts of changing demographics and overly stretched healthcare systems. With the lingering COVID-19 crisis, it is likely that the current trend of late prostate cancer diagnosis in the region will worsen with a concomitant increase in the burden of the disease. There is, therefore, a compelling need for innovative and evidence-based solutions to de-escalate the current situation and forestall the collapse of existing structures supporting early prostate cancer diagnosis in the region. In this viewpoint, we make a case for the operationalization of the World Health Organization (WHO) guide to early cancer diagnosis to strengthen the capacity for early prostate cancer diagnosis in West Africa using a realist approach, drawing on participatory health research and evidence-based co-creation. Ultimately, we demonstrate the potential for developing COVID-19 responsive and context-specific models to optimize patient navigation/journey along the essential steps of the World Health Organization guide to early cancer diagnosis.

Indexed as

COVID-19Prostatic NeoplasmsAfrica, WesternEarly Detection of CancerHumansMalePandemicsProstateSARS-CoV-2World Health Organization

Identifiers

PMID35646616
PMCPMC9104562
OpenAlexW4285143260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.